Haihong Shi

Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID‐19 Trial of Nirmatrelvir

Ravi Shankar Prasad Singh, Sima S. Toussi, Frances Hackman et al. · Clinical Pharmacology & Therapeutics · 2022 · 156 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of <scp>COVID</scp>‐19, in Subjects With Renal Impairment

Sima S. Toussi, Joel M. Neutel, J. Navarro et al. · Clinical Pharmacology & Therapeutics · 2022 · 66 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Calculation of embodied energy in Sino-USA trade: 1997–2011

Ranran Yang, Ruyin Long, Ting Yue et al. · Energy Policy · 2014 · 55 citations

Social Sciences, Economics, Natural Resource Economics +10

The use of chemical derivatization to enhance liquid chromatography/tandem mass spectrometric determination of 1‐hydroxypyrene, a biomarker for polycyclic aromatic hydrocarbons in human urine

Yinghe Li, Austin C. Li, Haihong Shi et al. · Rapid Communications in Mass Spectrometry · 2005 · 47 citations

Pharmacy, Toxicology, Analytical Chemistry +16

Development, validation and transfer of a hydrophilic interaction liquid chromatography/tandem mass spectrometric method for the analysis of the tobacco‐specific nitrosamine metabolite NNAL in human plasma at low picogram per milliliter concentrations

Jiongwei Pan, Qi Song, Haihong Shi et al. · Rapid Communications in Mass Spectrometry · 2004 · 41 citations

Life Sciences, Biochemistry, Pharmacology +17